Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy. [electronic resource]
Producer: 20131104Description: 892-7 p. digitalISSN:- 1537-6613
- Adult
- Anti-HIV Agents -- therapeutic use
- Biomarkers -- blood
- Blood Coagulation -- drug effects
- C-Reactive Protein -- analysis
- CD4 Lymphocyte Count
- Enfuvirtide
- Female
- Fibrin Fibrinogen Degradation Products -- analysis
- HIV Envelope Protein gp41 -- therapeutic use
- HIV Infections -- blood
- HIV-1
- Humans
- Inflammation -- blood
- Interleukin-6 -- blood
- Male
- Middle Aged
- Peptide Fragments -- therapeutic use
- Pyrrolidinones -- therapeutic use
- RNA, Viral -- blood
- Raltegravir Potassium
- Specimen Handling
- Viral Load
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.